Bioprinting Markets and Opportunities Report 2022: Bioprinting Industry Revenues to Reach Almost $1.2 Billion by 2028 –

DUBLIN–(GOOD BUSINESS)–Added the report “Bioprinting: Markets and Opportunities” p’s sacrifice.

Revenue from bioprinting is expected to reach $1.2 billion by 2028, compared to $182 million today. By 2028, researchers expect almost 70 percent of the bioprinting industry to come from applications and service revenue. The new report, “Bioprinting: Markets and Opportunities”, says we are years away from transplanting printed organs. However, bioprinting is finding a rapidly growing application in pharmaceutical and cosmetic testing. The use of tissue and organ printing avoids the need for animal testing and enables the study of printed tissue and organs as a true substitute for the real thing.

Brand Report

  • Digital printing and refurbishing applications are coming to the fore. By 2031, R&D revenue will approach $250 million in service/application revenue for bioprinting, but will only account for 12 percent of total service/application revenue. application to the bioprinting industry.

  • The researcher hopes to accelerate digital innovation in the entire field of bioprinting. The new report shows three developments in particular that are areas of strong commercial activity. One of these is the advent of organs-on-a-chip, a class of products that bioprinting has many possibilities for. The report also sees printers moving beyond inkjet and inkjet. About 20 new methods of bioprinting are emerging from leading laboratories and hospitals around the world. While more than 90 percent of bioprinter revenue will be generated by 2022, by 2031, 15 percent of bioprinter revenue will come from printers. based on new technologies.

  • Another technical trend that is driving bioprinting into the digital future and will improve the cost to patients and expand the potential is the move to next generation bioprinting platforms are more powerful, automate many tasks, and integrate medical functions that go beyond traditional bioprinting. By 2031 it is expected that the researcher who is installing digital or bioprinting standards will accumulate $100 million in revenue.

Main topics include:

Chapter One: Overview

1.1 Background in Reports: A Reformation for Bioprinting?

1.2 Bioprinting: An Attractive Business Opportunity Moving Forward

1.2.1 History and Purpose

1.2.2 Bioprinting Industry Structure

1.2.3 Innovation of the Bioprinting Industry

1.3 Different Locations of Companies

1.4 Objectives, Scope and Plan of this Report

1.5 Method of this Report

1.5.1 Overview of Methods and Concepts

1.6 Key Points from this Chapter

Part Two: Bioprinting: Market Drivers and Market Challenges

2.1 Things that can lead to the “Bioprinting Time”

2.2 The COVID Factor: COVID is a Bioprinting Market Driver

2.3 The Elderly: The Role of Bioprinting

2.4 Bioprinting, Personalized Medicine and Bringing Healthcare Closer to the Patient

2.5 New Technologies Emerging Since Bioprinting

2.5.1 Challenges to technological progress in Bioprinting

2.6 The Increased Opportunity for Practice

2.7 Impact of Government Regulations and Funding

2.8 An Access to Bioinks

2.9 Bioprinting Considerations

2.10 Key Points from this Chapter

Part Three: Bioprinters: Technical and Market Evolution

3.1 The Essence of the Bioprinter

3.2 Extrusion Bioprinters

3.2.1 Examples of Extrusion Bioprinters

3.2.2 The Future of Diffusion-based Bioprinting

3.3 Inkjet Bioprinters

3.3.1 Thermal Inkjet for Bioprinting

3.3.2 Piezoelectric Inkjet for Bioprinting

3.3.3 The Rastrum Bioprinter: An Example of an Inkjet Printer

3.4 Stereolithography (SLA)

3.4.1 The Problem with SLA-based Bioprinting

3.4.2 Making SLA Bioprinters

3.5 Other Bioprinting Technologies

3.6 Ten-Year Projection of Bioprinter Market by Printing Technology and Printer Type

3.6.1 From Bioprinting Research to Biofabrication: An Overview

3.7 Key Points from this Chapter

Chapter Four: Bioinks

4.1 Bioink Introduction

4.1.1 Horizontal and Horizontal Basis of Printing

4.1.2 Hydrogels

4.1.3 Stem Cells and Bioprinting

4.1.4 Spheroids and Organoids

4.1.5 Ceramics and Bioprinting

4.1.6 A Note on Printing

4.2 Types of Bioinks: Application

4.2.1 Bioinks Market

4.2.2 Functional Bioinks

4.2.3 Bioinks Support

4.3 Materials for Bioinks

4.3.1 Acerose

4.3.2 Alginates

4.3.3 Collagen

4.3.4 Gelatin

4.3.5 GelMA

4.3.6 Chitosan

4.3.7 Hyaluronic Acid

4.3.8 deCM

4.3.9 Fibrin

4.3.10 Cellulose

4.3.11 Silk

4.3.12 Bioinks are based on the extracellular matrix (ECM).

4.3.13 Role of Synthetic Polymers

4.3.14 Smart Bioinks and Bioinks with additional materials

4.4 Removal of Pet Products

4.5 Bioink Supply Chain and Purchase

4.6 Key Points from this Chapter

Part Five: Organic Identity Requests

5.1 Bioprinting Application Survey: Introduction

5.2 Bioprinting and Medical Model Improvement

5.2.1 Organ-in-a-machine

5.2.2 Disease Patterns

5.3 Skin Bioprinting

5.3.1 Background on Tire Replacement

5.3.2 Print and burn victims

5.3.3 Bioinks for Skin Bioprinting

5.3.4 Examples of cosmetics

5.4 Publication of Bones and Bones

5.4.1 Materials for Printing Bones and Tumors

5.5 Organ Printing and Vascular Printing

5.5.1 Competition Between Printed Tokens and Live Tokens

5.5.2 Publication of the Plan

5.5.3 Library and Shelf Storage

5.5.4 Liver printing

5.5.5 Endocrine System

5.5.6 A Printed Pancreas

5.5.7 Publication of Seeds

5.5.8 Ring

5.5.9 ears and nose

5.5.10 Eyes

5.5.11 Heart and Vasculature

5.5.12 Bioprinting and Neural Tissue

5.6 An Introduction to Dental Applications of Bioprinting

5.7 Key Points from this Chapter

Chapter Six: New Directions in Bioprinting

6.1 Introduction

6.2 Weak robotics

6.2.1 Soft Robotics and Bioprinting

6.3 Food Printing

6.3.1 Drivers for Food Printing

6.3.2 Food Printing and Food Planning

6.3.3 Food Printers are now available

6.3.4 Bioprinting animal tissue

6.3.5 Barley and Chocolate Printing

6.3.6 3D Printed Restaurant

6.4. Pill Publication

6.4.1 Manufacturing Pills Using 3D Printing: Advantages and Disadvantages.

6.4.2 Setting up a Growth Industry

6.5 An Information on Medical Devices

6.6 Key Points from this Report

Chapter Seven: Profiles of Nine Leading Bioprinting Companies and Their Strategies

7.1 Criteria for Classification

7.2 3DBio Therapeutics: Total Process Bioprinting for Healthcare Services

7.3 3D System/Systemic Bio: Is It Making Its Way in the Bioprinting Business?

7.4 BICO (Cellink): Bioconvergence Conglomerate

7.5 Cyfuse – Japanese Bioprinting Firm

7.6 EnvisionTEC/Mea Park: More Interest in Bioprinting

7.7 FluidForm – Building Relationships with Important Companies and Technology

7.8 Inventia Life Science: Proceedings from research

7.9 Organovo Holdings: Greater Focus Than Before

7.10 Rokit Healthcare – Korean Bioprinting and Google Cloud

Companies Matter

  • 3D System/Systemic Bio

  • 3DBio Therapy

  • BICO (Cellink)

  • Cyfuse

  • EnvisionTEC/metal computer

  • FluidForm

  • Inventia Life Science

  • Organovo Holdings

  • Rokit Health

For more information about this report visit

About is the world’s leading source for international market research reports and market information. We provide you with the latest information on international and regional markets, key industries, top companies, new products and new trends.


Also Read :  Pharrell Williams’ Nonprofit Gives Grants To Black Entrepreneurs

Leave a Reply

Your email address will not be published.

Related Articles

Back to top button